{
  "experiment_id": "0aace192b506e5d8a02c63e86b41dd2c",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "a2c885aa2a82bb5b150f213062bbeb89",
  "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.0,
  "thinking": true,
  "tools": [],
  "timestamp": "2025-12-11T03:48:06.476292",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3081,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 332
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01RKPou5FdXNou2VP1hv2Ryq",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze the input data and map each field to the correct controlled terminology from the Target Schema:\n\n1. **diagnosis**: \"Neurofibromatosis type 1 microdeletion syndrome\"\n   - This is a specific subtype of NF1\n   - Looking at the enum values, I see \"Neurofibromatosis type 1\"\n   - This should be broadened to \"Neurofibromatosis type 1\"\n\n2. **assay**: \"clinical whole-exome sequencing\"\n   - This is a narrow/specific term for whole exome sequencing\n   - Looking at the enum values, I see \"whole exome sequencing\"\n   - This should be broadened to \"whole exome sequencing\"\n\n3. **tumorType**: \"Plexiform neurofibroma (morphologic abnormality)\"\n   - This is a more specific/technical term with a qualifier\n   - Looking at the enum values, I see \"Plexiform Neurofibroma\"\n   - This should be broadened to \"Plexiform Neurofibroma\"\n\nI need to ensure I use the EXACT values from the schema enums.",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3081,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 332
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3081,
          "output_tokens": 332,
          "total_tokens": 3413
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\" - removed the specific tumor subtype detail to use the standard diagnosis term.\n\n2. **assay**: Broadened \"Illumina whole exome sequencing\" to \"whole exome sequencing\" - removed the platform-specific vendor name to use the general assay type.\n\n3. **tumorType**: Broadened \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" - malignant triton tumor is a rare subtype of MPNST with rhabdomyoblastic differentiation, so it should be classified under the broader category.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3076,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 645
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01N6eSdtAjHqQtg8XLEY4H5V",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze the input data and broaden the narrow synonyms to match the exact controlled terminology from the Target Schema:\n\n1. **diagnosis**: \"Neurofibromatosis type 1 with optic pathway glioma\"\n   - This is a specific variant/subtype. Looking at the enum values, I can see \"Neurofibromatosis type 1\" is in the list.\n   - The broader, more general term would be \"Neurofibromatosis type 1\" (without the \"with optic pathway glioma\" specification)\n\n2. **assay**: \"Illumina whole exome sequencing \"\n   - This mentions a specific platform (Illumina) and has extra whitespace\n   - Looking at the enum, I can see \"whole exome sequencing\" is available\n   - The broader term is \"whole exome sequencing\" (without the platform-specific mention)\n\n3. **tumorType**: \"malignant triton tumor\"\n   - A malignant triton tumor is a rare variant of MPNST (Malignant Peripheral Nerve Sheath Tumor) that shows rhabdomyoblastic differentiation\n   - Looking at the enum, I can see \"Malignant Peripheral Nerve Sheath Tumor\" is available\n   - The broader term would be \"Malignant Peripheral Nerve Sheath Tumor\"\n\nLet me verify these are exact matches from the schema:\n- \"Neurofibromatosis type 1\" \u2713 (in diagnosis enum)\n- \"whole exome sequencing\" \u2713 (in assay enum)\n- \"Malignant Peripheral Nerve Sheath Tumor\" \u2713 (in tumorType enum)",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\" - removed the specific tumor subtype detail to use the standard diagnosis term.\n\n2. **assay**: Broadened \"Illumina whole exome sequencing\" to \"whole exome sequencing\" - removed the platform-specific vendor name to use the general assay type.\n\n3. **tumorType**: Broadened \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\" - malignant triton tumor is a rare subtype of MPNST with rhabdomyoblastic differentiation, so it should be classified under the broader category."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3076,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 645
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3076,
          "output_tokens": 645,
          "total_tokens": 3721
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Watson Syndrome is a variant of NF1, so the broader standard term is \"Neurofibromatosis type 1\"\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - Broadened from platform-specific terminology (MGI) to the general standard assay type\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Broadened from specific subtype to the general tumor classification",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3075,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 639
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01126GbbZaLNCHWPfraWmJi8",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Looking at the input data, I need to broaden narrow synonyms to match the controlled terminology in the Target Schema.\n\n1. **diagnosis**: \"Watson Syndrome\"\n   - Watson Syndrome is a variant of Neurofibromatosis type 1 (NF1). It's characterized by NF1, pulmonary stenosis, short stature, and sometimes intellectual disability. It's caused by mutations in the NF1 gene.\n   - The broader term in the schema would be \"Neurofibromatosis type 1\"\n\n2. **assay**: \"MGI whole genome sequencing\"\n   - MGI (MGI Tech) is a specific sequencing platform/company\n   - The broader, more general term for this would be \"whole genome sequencing\" which is in the enum list\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\"\n   - This is a specific subtype of MPNST\n   - The broader term in the schema is simply \"Malignant Peripheral Nerve Sheath Tumor\"\n\nLet me verify these are in the enum lists:\n- \"Neurofibromatosis type 1\" - Yes, it's in the diagnosis enum\n- \"whole genome sequencing\" - Yes, it's in the assay enum\n- \"Malignant Peripheral Nerve Sheath Tumor\" - Yes, it's in the tumorType enum\n\nSo the corrected metadata should be:\n```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
                "signature": "EskLCkgIChABGAIqQAxgPwlXmU33ExAV/FapqX1lDQNSGf98cjPXcKQ7EIH08iGNtGSeVKr1SgtHvIyI/Meop0d8cR0rM16sdyReNuUSDBNwqG8UkkfDHIACnxoMtDb0NzKn0hCrkHcWIjAYawAMcD4Bn0laBdH2pPeE4MrQmUHhftDM6x/qfEkX47xLyC5QX6J1KZRRnmDdD4gqrgpZ54Zv/Lo3sEcc+bpQ/Pz6NX3NT0cSi8Zq2XVMAQCDBHfXYgB0TwwQn5feO7isLv4gsMRpBzF9rLLI3y/c2R7W2ooiBobG4nnlm6+RJ8kVE6fS3EBxup/0zLfKX03hipJ9fgrc9Yny+/jyd1ssxCppkLx8F0F5wokXdXMHbFV0Df8n0WH4hK7mQ/jJ/sLGWhHCxvv1BNS41MfOW3fkJDzHzP7U0nhD21N2mC8b+o3Umf5BxLxeEIIiEJqSz84hXNLnsRBcz/RJT7hRsXjiZTODJs0nfMYP5hPlSvSnqJyYDHHGJ+Es7R27MelpRGWsy9D4mHepYOO7EqsM1s6zbDP9AxHhkVzeN/1sx7oCX5raeK698518ibGDPw3jNhfPqpwD+9aFo76XLHDYL+NP4e6mAPZ/YfERwbzhnWsm9e6uldj3TUN05SYfipdcxJZfLzLS3hiDtEdgxNw6Idom6CTCBdrXzl8iEj3ZPuu4svcVPRNt+YabXhHFAKo279Yg2evP1AItiGDQLvrGPewtwQIeM4xeFnGCtziYNNw22yBvnbnCSPFOFdnPHENZbYO93lR74qh+V76iy/SwZlV9H8w4dC3E8V1O5qroNLUwMKzKubQXmllBd3eqm8iTqjhRN66VbVjTpMh90RCCtK5K9pgiCfw2J5bqDpaShtpXcdW9g6ksYSHZ9kGdLugF0K3nudVwBeiEU8yoOLDo2MuYH5gaBsJOigamdHoVnz8cS5jDhPSzgRu+3RWfXCii8K12MhNOfyXWoTXjWWTGgfye2Yh6OuqcY2LCCjKu7kif315uxCxAXW9AmcQJUlMXsfrUSLNWDlaMDkjmDD63KetZuHpJT5ZBjUW0HYULbvYlgvIpXYwhvtVbZ8piPWmeYbQda9657jnaDaarZDsgJp+uE6TzNUCPk7S7052t/mSje69Ula2Zx+XmDZMHO1UhtR3jIT7/OaAi7Kod9/V2Vc0cR3jBtbZpnF1iZ2msp58o9NZqIV1DM8byujXE3AB+FmZuih+eiQVTuw5y1OsoQb5pZBurI7jlrdAmotmX+1z3DpeFtrjRmhXAj06oaC/aostmOib51nTfjxuCqTlVcji7nRWQsExQnVXEEEgnLd7NBrZFEAlZL+ND2csv9RZd+qsCYbgVwExJDiHrQbcK7x/udiDO398g6MV6suFQr5bVXAg6UDBpHSoPnS1raqO6UpIzTu8k+asa6MDYzLDennfjxe91Fb/HMJzcvviiz1GH/3QD2rtSsHBuh3HGrSK5mALuLwQgbIJpHc89o40L6MQhnXTthfzkSU2Ff/6gbyVmKw2rUTYSHjiF1o6YxbaOPrkA4rkuNclLZ57ZagplZijqNouSnCLS6apLf+00t20Cy4stzWxZ1DXPbhEGc00rXYWruNDKFpMePPXnT3KNnQRGHBwWulvc39xFsuhYkQU5iDOolMvUj5TUaPc1Hfglehd6SORePVP0Zn1x4IZyHnZM3FA1d+vYTKJ/4+GynwbhG7iBJrx75l6wpq0rAVtxjBVCylNhuDi+RD8YznNxG7epnzptXiaX6sNtgXPmUckPMQr5dhKSthI1I5TS1xvgQ5sG8PaKgAP5ILoYSD9iFlllNEc2P17Di/7ZxGFegHOA6YyZuWAGBTusXASxuF8btA6u9isJ4m+lDgyswrs6yPbhsdBJUFbGNughhw06g8eSYP6f6vRu4vA9kdpQSkowPUo2njwJJyjEe+9Fbysm8gHoUxbrQPTYtWwe432bo3JqaeMYAQ=="
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Watson Syndrome is a variant of NF1, so the broader standard term is \"Neurofibromatosis type 1\"\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - Broadened from platform-specific terminology (MGI) to the general standard assay type\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Broadened from specific subtype to the general tumor classification"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3075,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 639
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3075,
          "output_tokens": 639,
          "total_tokens": 3714
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"NF2-related schwannomatosis\"\n   - \"Familial spinal neurofibromatosis\" is an older, narrow term historically used to describe what is now classified as NF2-related schwannomatosis under current nomenclature\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - \"Open MRI\" is a specific scanner type/configuration. The broader, standard assay term is \"conventional MRI\"\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact controlled vocabulary term \"Unknown\" from the schema enum",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3063,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 1232
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01FoB7T5bNY3KPVsZbJvSRyF",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze the input data and map it to the controlled terminology in the Target Schema:\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\"\n   - This is a narrow/specific term for a type of neurofibromatosis\n   - Looking at the enum values, I see:\n     - \"Neurofibromatosis type 1\"\n     - \"NF2-related schwannomatosis\"\n     - \"22q-related schwannomatosis\"\n     - \"LZTR1-related schwannomatosis\"\n     - \"Schwannomatosis\"\n     - \"Unknown\"\n   - \"Familial spinal\" neurofibromatosis is historically associated with NF2 or what's now called NF2-related schwannomatosis\n   - However, given that it's called \"neurofibromatosis,\" the most appropriate broader term would be \"Neurofibromatosis type 1\" or potentially \"NF2-related schwannomatosis\"\n   - Actually, familial spinal neurofibromatosis is typically associated with what is now classified under NF2 spectrum or schwannomatosis\n   - But \"neurofibromatosis\" without specification typically refers to NF1\n   - Given the uncertainty and the \"familial spinal\" designation which was historically used for NF2-like conditions, but the term specifically says \"neurofibromatosis\", I think the safest broader term is \"Neurofibromatosis type 1\" as that's the most common form\n   - Actually, thinking more carefully: \"familial spinal neurofibromatosis\" was an old term that referred to what we now know as NF2 or NF2-related conditions. So \"NF2-related schwannomatosis\" might be more appropriate\n   - But the instruction is to broaden, so maybe \"Unknown\" if we're not sure?\n   - Let me reconsider: The broader standard term for neurofibromatosis when the specific type is unclear would be... well, there's no general \"Neurofibromatosis\" in the enum, only \"Neurofibromatosis type 1\"\n   - I think \"NF2-related schwannomatosis\" is the best match since familial spinal neurofibromatosis historically refers to NF2-spectrum disorders\n\n2. **assay**: \"open MRI\"\n   - \"Open MRI\" refers to the machine configuration, not the imaging technique itself. The standard term would be \"conventional MRI\" since that captures the basic imaging modality without specifying specialized sequences like diffusion or functional imaging.\n\n3. **tumorType**: \"unknown - no information available\"\n   - The value explicitly states the tumor type isn't known, so I'll map this to \"Unknown\" from the enum.\n\nMy mappings are: diagnosis to \"NF2-related schwannomatosis\", assay to \"conventional MRI\", and tumorType to \"Unknown\". Actually, I should reconsider whether familial spinal neurofibromat\n\nosis truly maps to NF2-related schwannomatosis. The historical terminology for familial spinal neurofibromatosis does align with what's now classified as NF2-spectrum disorders, so this mapping holds.",
                "signature": "Er8cCkgIChABGAIqQLBR06zqUjDERF3apJVwVFACNc7vkFVN4e5wy1ZrzZCQsSkVINmdmfSfKEHnNLmH/A2/Qy+UQKN36jzAZ9ym8KYSDPBoHr/N3b0d3CSeahoMHSuTE/kHA5gKpRUEIjCe4Z0w6SXAyuVpnl1VKP2Ara/3P2wKiKAXJ1q1HWy56/Gwdbzc7wwxqr65rCw9BcwqpBuBh25QgWhG3kKvonaE7uDG5gSb55zJ/4sntKg7rNb33q48HJOaq/cRa3G8dcv4yeLLJEJAPi/oExKDDhDjs4xnF+eHG8qJDKJ82Tk1/pVwo8nH01hpjvNN7dYiX0WCdAJ9OPnTsgqXaux35pJzQJ1VZhhXYaNnsiPf25+7WORbccNPhHxM/2jJwg5wDnzzdIMHDA5JBnrfYZPc5DQB+ZiQxX8kxb2s8oE39Cp5Jj+L0xkeMRj7MFlKXf8qEZvmCXZFCPEbkmMpDG5NMV2K49rP9QIjdYXhoBgKOu566FPtraQ6d0lDkF627R0TbxV0Br/7qf7cHHv9u72GIugXb8WFyxE0EBoO0QLxgmJ5sFjW3YghoxvX+6rcB6YmSnexJWvnHmSKxl+u9FD4geZ2I+9V3xAbws7itygIFtYXJgRygfxpHQjtRHQ4zZo0Uk8OLamW2YOTcexh22d6yqcOvmNwMGhzv//1ch7/W+CMG/6mNVnDtLgVUIbnPjkPsEgiQPSitJ1p200HEOxV7QPGh410FcxTv1arG8EdFltKspeKO063ciuqY0c8apU9gLWyhUpjpw1LRnqn3GVMigm7/9xxesRTNTNexr1haKlPtzSAib5msBDrUTk/r2uaoRApbDYK8AvDIO/iBP1H8EEHACkKoVXG9x6fq3g44K9NSqZO1IAAtzMfu0E/VLajjEUGZMRPTof0FBdQcicJSBczH7cFQ3hFj0jBZhkOWoRzkBfOLzi4VesQS+RfA5cNMzPKVjyQJTiTpVtIgNJwTcLTCR9qcG9JXZDoACcXT/PjC91C5jiJzL9UBsJVvufxhrkgG3e6qOR2Aahx+pyPaFRq04PfHsBL5O5r0HBInEcXUioQ9NtBCYOnz1QRsw1BO3UevVOjiNLD0RORPIo5b3aHT3VxwbvOYKilt+AuHkyYPncJP1oRR92NLiojKFo6Yss36GYM9iO9N3RfFOsSG9O3leVIfh6wcRnotDf0Pdyx1oJaUf44fN3u2cuvG0JUCwtrwNDNuB5WLRUGnUpU2FQ4xXuCeNmgQxzT7tFBQUWUMjOyKmrb9nw3CJPKJm7/T+6ozEEBHf3hKFnCjvGNOnWJo5CTwEyV+EP4yYlc+GbGaVxsqIx/BkU/jVQF5q6VfMd7GmM9KtyQCe+F+NXIpeEDMEuR7726QlOIzsIK50nOuE5s/uJQnEZv+0cqOqFx3Z0ZJATZVOhBTcEPZSyF79/DIYtpI/Gr2GPGF+PQewF/b6GFG97NOZdlUdMF+0Z14m2YK8nfUxAN5LJ1y2MuHfEJJoz3AEcHmnff2QLPLLor4Jzp4lXueZA9tN9IbDnfajrWnax/A7f6CA3bCldWZx502prS++wvkOfPujOrmKl36pyFlKW3dyTSB0e1i1livwpGadr7MHmM4Cplj2L7fS11xYjeYbklZshNRCjDY2+DRG4xaoRoavG/ZHVkFZA03Uzx/UnTd9x+/j86m/uCur+sbL6o7js0kwHDxoCQih9QFpgl9cVHmOXkvCBUBxG4OLDv1ugsr46EhLfKnAlw3Hh9KdrAQUFuwvrtUOv9kZof2gLa/e9CLuMX9MmTzZ6uGV0dM2pHBE1Sys2tEcsv4a8mxM0OTlS1B8q1484ZG6B/R0I8uIuLJQKYlUOEgxq9PLrf8rIzsHCW2JUUd9Aa+T/Q3czE4f4/4S/b12M4HySxsiEQ4D9/FTMPIXA4v4/uQDYIHxG0hpSbmEjwp0p642MfF01gOOAa8kEauuJU0bpsk0YnDHEIOAXCpYf8xfmtxxiUBe7YHJ6ESFxvz6CSvSvfhGw7Ex2/56swl4oYMquqR0vuWgZfaXYqzJF9XRGe6tPVxGmhai56Me1DkEtbHYcuT+TKWHxgHeO2q8sguOPGTuUUlwEWDX56hF2D8yQ14e43vQayGTylW1zpqVqC5O3tSKo23x7ucxARgvq7GwH6rGKW81S17lc7asEbJ+4KFy+NK++z4Pe7MnuVrnTtemvTeJMG5786Ych0Moul4OBENVeuxG1Aw+7c3HgLOpVHgr8UtNjiuFHfZaivJtMpP2OXHwiWcItUnTR7GIVK34rDtjYM3ABLm1WTAlxWIpjU4atMSKc7MWF4br/NrABx2J+W39yS+n1vK8xU914xfTWtbh3g8mIOb+0mF7OPeiMqfFHAHrTslR3Vtv7L1X4g+Ja68uECg4Em60i8TlYt++ejmIFxNqumPBpuwtSy1D28o5fylagJPxV5w8A0ElZqNFqkzqW7tEToJBti2f9EeEKF0GKfQOnQG8ygaQs4bpa37McQwi5cK79w1sxn9T9GgRGKQn5fcOpe2pIqIhhXI/qzl8fC/32+uu2Awd3Ulg1eJFvcG4VtdDk38xBqhwoOiL0hIR0sybimDrBnOXhJ9P36YO6orqAzUrFUp2DR1e3/jPrFOhaFH8J296N8OsrqxueJXGGewFhl/wb9cahrMqyCd2gagoXJyRleYmrnjv1U2dI5rYHIabddzZr52waBAXcBtKRaZ2uAk6PQp43p5V+B8QIblH6XLFdUvZUSWACvjutUxjCi76mRkosE9Cfw2NYbVlbzv2o7htfCg+V8DNpRYDRERJF9JsI2RHNSWtof2ED9z3r/Kwi655x6STej1t8VJ3vrJ2IlVZ/ufNydDwkXu8ztrZAF8YDi2nGrv9XEiJ0VIX//WTSYVcyeb4fgl3cAMnhZAvsrcJSfH142OVuj5kXlhBHT7KhvFHZexfqQhSN1aaRDhRlYuSSJ5HfGOTSMQqk/J03bYzzBuwzwDlzNisKXAs4dUdkFaxhYCgz1jRNTXycybcDuOxVmePWba44mslts7taW7Sk55SL97YkubGsT3x/KAt/FcdQUbUSc8pqPFyvJ2fjeNWh8oWr43WBIt4xtshseL3GLT08SF0tazAPbzI2vpKO1vF19qSNkW/EX00e/OkJn3q/upCdv4eNLW03Bt6Hnl/+aYr+jUaPhlxY2q72VFXqaEaZh4vdPoCLB+eQg6ghZMAptF8nZuI17R2iCTZIeJaOl0Fvkq4ZL8wDbU2gDD7jI+Zj75IL5xuBWoCuIS152lXX2XH8PcrucuDNK5LCkGqj/NrEOHes/muWUfRViZFDwRQXPZFmDucIQsCetETokMvpI1Kl+Q1w4fMBnJ7VyZiBgZOPufHikD5uHlv3J701UsmcTT5w/IC+ubWk0FIgkt8+hQCqSWAUebBr/cVFG4XliJcIUw7NPO5kKC0Uol/x6oA0aer8b7yePmba55HyAm1dL8uLM8N8jC72Z9fkJ0Btd/o7gncyeg6/OF1Y8deeAEX+LE6pC/+4TYlTyze0x7jEj4upmqnVH4MVr2wnA9bR98btiO27Oj95SHSTJbo3s221rueInwypeff7eaeCT1j+67EFuKgwTj+VyNAn4Y8lbiM3nERp+JZeZCSpfzoetyB268u7fOS4WyK3vV/eHErv1IvjFuYb2+0Bvbe1YEEglIHiAH+OwSungdSbDPrFGItmAWi4J5lKqchioNKDK0eD8laDJNTm1+Ncjqwoqdr91wIoikOW0q+shEQNzD0MWpY/mHchVzggZGg4z/2FS4qbwADJAuQ+9klgWGiw4dOlHkNwEwtco55U+rhCAGdLWqGNxhnlKS5JvIkyB0Sy5JYSdWOcqPF7pFvIRj3dZJDXR89eOHKVOwiyzlWpuJs+lBZMY0VezB8vW5UvoRsv1JRkfSzerwF/3BycEniEXOJo2FvXqytceyd3ZiPdFiDAwREFxpIZpC0wbtX/q9/UgzCcfJyMpu6fF3kJ/Nm2fV/zsmexF9rHnRmPs5KgmPWAK8Hv28JF6VX4fRGVeogoQREMAnG2mvzbCYvdkVFo9Njjum/c2w+k+y/S57c0EniOCOB/K0Vyun4f74VarFDyYYLlLqI9MbCVjalNUFtQImqWChl7RAijeqrZ75auLE8l7RAPtHu0ohIDHSh+9DV3+TMJ/wCLnotrzVDVuFQpaDDN1a+54Fp/pPbuy36Q477JNf4bAayXjTVonShdOnN/ithPGg1j7r46kJOkFEaBQExhiMd5QHNv5+vEWhEFn+F7BPLnsAmH52KeqfrV96cLN49MXPgXvThv/aG9GuK1p5ci+N04JBpy+x0UzrJnSL+0OKN+5j67qHhonrK+Q5Z4P2WOo96cWeUs3OXOpw59/pNa/p8Td/ONlii6MZb+sVqhdvAifbc/OzsL9IgD2iwiK8+u8j3iXJitKH/vF2sYBfMypu6Xtw8knELc6IoTxGxqwva3dnhMejuy/lhX6i37/1t0VtJdlYNXvpOUYEeZFw8j4O3M1KMApynIjLCfB7Sgs6hMeP1ou4sI+N3JJQ6fGpDWKbOWfxFFfTU4wGwJQQ413W0RdTeCRLjhCDdzzXSXu2MXqh5AH5+GdpXTs/8qeVRBBIYGNsskov3dOXziXc8vDo3LJTENUMILOcTZjDWMKmiIx6xmCsd9TZDOBpETBYPBKLCRyi512qc6lZAXKZQaxPteknLubJ8v2B6B3B6Q1yBervNzsl52ojmlp6tdLJH/W7x6hWg0PmnV5aebj+n0T692eHf47riAr/aj4L1AT1ZrT/mucXq84KxRRgPrEobjrnj4/xmRix/fPtfBEjrF99cJcSYRjKySV31beI6gYAQ=="
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"NF2-related schwannomatosis\"\n   - \"Familial spinal neurofibromatosis\" is an older, narrow term historically used to describe what is now classified as NF2-related schwannomatosis under current nomenclature\n\n2. **assay**: \"open MRI\" \u2192 \"conventional MRI\"\n   - \"Open MRI\" is a specific scanner type/configuration. The broader, standard assay term is \"conventional MRI\"\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact controlled vocabulary term \"Unknown\" from the schema enum"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3063,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 1232
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3063,
          "output_tokens": 1232,
          "total_tokens": 4295
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Not Applicable\" - No change needed, already matches the controlled terminology exactly.\n\n2. **assay**: Broadened from \"immunohistochemistry of skin\" to **\"immunohistochemistry\"** - Removed the tissue-specific qualifier \"of skin\" to use the standard, general assay method term from the controlled vocabulary.\n\n3. **tumorType**: Broadened from \"Cutaneous storiform neurofibroma\" to **\"Cutaneous Neurofibroma\"** - Removed the specific histological pattern descriptor \"storiform\" while retaining the anatomical location \"Cutaneous\" to match the controlled terminology. This represents the broader tumor category that encompasses the more specific storiform pattern variant.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3063,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 765
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_014t8tbn9kHJRQMwqmCNrTSj",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "I need to broaden the narrow synonyms in the input metadata according to the controlled terminology in the Target Schema.\n\nLet me analyze each field:\n\n1. **diagnosis**: \"Not Applicable\"\n   - This already matches exactly with one of the enum values in the Target Schema: \"Not Applicable\"\n   - No change needed\n\n2. **assay**: \"immunohistochemistry of skin\"\n   - This is a narrow, specific term (immunohistochemistry applied to skin tissue)\n   - Looking at the Target Schema enum values, I can see \"immunohistochemistry\" is available\n   - \"immunohistochemistry of skin\" should be broadened to just \"immunohistochemistry\"\n   - The broader term removes the specific tissue type and uses the general assay method\n\n3. **tumorType**: \"Cutaneous storiform neurofibroma\"\n   - This is a specific subtype of neurofibroma\n   - Looking at the Target Schema enum values, I can see several neurofibroma types:\n     - \"Cutaneous Neurofibroma\"\n     - \"Cellular Neurofibroma\"\n     - \"Diffuse Infiltrating Neurofibroma\"\n     - \"Localized Neurofibroma\"\n     - \"Massive Soft Tissue Neurofibroma\"\n     - \"Neurofibroma\"\n     - \"Neurofibroma with Degenerative Atypia\"\n     - \"Nodular Neurofibroma\"\n     - \"Plexiform Neurofibroma\"\n     - \"Subcutaneous Neurofibroma\"\n     - \"Atypical Neurofibroma\"\n   - \"Cutaneous storiform neurofibroma\" is a specific histological subtype that is cutaneous (affecting the skin)\n   - The broader, standard term would be \"Cutaneous Neurofibroma\" which captures the cutaneous nature without the specific \"storiform\" pattern descriptor\n   - This is the most appropriate match from the controlled vocabulary\n\nI'll map the metadata to the most precise yet standardized terms. The key is selecting the broadest term that accurately represents the original specific description while aligning with the controlled terminology.",
                "signature": "Eu4PCkgIChABGAIqQEIMWtD2s02ufe193HLMhQxVw8sEnblxTzbvE/Kt9wGXQdEObHQ4BBY94cDt3/0OeIy1ykOLKGa2k3DRVTxODJoSDMnKi8yu4J8xJLGRhRoMNKBYcJ6haNusUDDNIjCzUz9VDBJCMAZSaplRzn7G4Uc3PztgYB1FvwCMZV5a3NJm3J/pAl7mXDkufPcTAgAq0w4qH4MSlkHsGuuSxzDmdmddl9v68VplhvCPyRJnRyjyQu0ARHHQvisZwZY9oIzBzhB8SpOZcl9ua6/H/StCs5ZOTw31FLtZBs5MPuIapdFTen4w6BXeXWCeGRkDB0pUll5JcF28Zj3PQIVUCO5YPBtNWI8DphBi3ku+nHWpMNexh4k7Xz6BhpuQBUEK/xTKxuRS/MaQWDYX7nwV0kQGqgPoGDPAKQDBywUcU1K6FiH/gRJNj7BdqS0Wizih6QPM+ZubqpAtujEoxqVQ0K8+1me9hDl+loOm5i3SlaQpB3N5l3DU6pnRXxLvY7ik0fJxmKQx5IoZadMWt2BSCo7Uat7jmqDRAetZjVggNQHlEqIGZMdTRYogaPtdUHxaQ24x+rqZtjEI5TQIJMeSal7fbu71m8Nem9dd+Tt2xSTgvK84esMfEbO88t553oQWfJHxPO68IQRNtcrBf9HMVc9MCAlpxWjNwC4rYFUIIjSm/4O2ul4hFvHFclTZnDJ76cOmzdGetHaOJmbr4CYhAVj9c0VDiP/H7UmOvesRxKDLQ3dDuDFmUCUZH2d31YWdl7RtVdkCbCRXffXM/V4euXEpYcy5xATFDJUbjkfOGKxxpbKvwpKzX5z2r4lLjmTm/TJdeHAdG6EfDPXueSe2ODrzdA5lAfjTXWX+6DEhiG5M20CwPXSDQLClsfYExTE+m3voi7W2uMig//gz5MzZjsgUgqNom0TG3Ke0d2aKOiwqgSP5VIc6Jpe39MeT6GAmWCxnzrJDIMBq/qJCGYwtMMF+cDmIrjodsm7c/OLOt+gaSM7XEtu+7V2oXn9wgLVlWRh5z0q599jUlWttoF9Vcslrf8mELC2EFXTFCdKnJQdVX6lZEQ8mnizVDfSG/j31NvTvPXWg28FFuQ2L/dOeoYhZx1IvD3+eADW5OMBECAJ8gXqUu1WdozGf5F+f1deq77lu+yyM6Dzv2uz9lk8oi3qP9aT5qmriYRWhUuled75rUSlORxz1z9QHoNTSd2bBdmMxu+jh8vaW3bhehhANUWVTSyy7jmoglAsof5UXaxMU/qxKkCwRgPMhoOWIveBbdFyzfySiqHw4O5SmA7mTJpJcRpdWa72KQnnhukEOzcLiI/NvEFHLF9UftkbW1BcdlBMlL0Fbzu/JxIGjCvHbvgPq3PmN67C00UFaf0T6FSwFNZG/ybGMt5NBJWWJ7+wpdG5nLBFvEWw/5+6TQfXVG0qQ57NePVlLipYwMfIMp10g62WiFH6l6GJQ15pvxOkM/3DdJLx4dJQDl6vqKn6fROHG6TMi1cvQjU4sb2ERHsnSt2ZU5mRi9pNIP3ZXXelCJ3Ja1aNMe6vBF2nBfP7gzPSC2yOqGDExlo7dJhO96MvNtu38x7OuqNeVE5lUg+BJD/3ZaSVoRm0pAkFrUvIImTE1DZiv5WHz8cBUYlK2b+deW4GcqU9FGLNcHVsG8X2jy5RrO2tM/GFE1qAfAVhFBc2Niruv6rj/aGOGy/DsAIsV6t2ZE+6wbSfAAljvhg8pdLY7UJtHdpB3WeabvGTflL5z08eEsYa6OVzuePhLuft+d/VV+4/s5ifFl0a/03UyPWe15uHiGqoLrBt+PREDdPrwXqk8N7wqgyikCHTy1EjcRf0KHoweO8SLKPKcC8HAO2qcf10UIkGA50odm8bHUwD82Ln+l46BXTWhlL11bLNtwTKLYLNw0TMJZKgCJbFzPbu5K5/mQY8DiMFnvw9xalr8RpdGERAC/98VMSJicmOGXxwfN32SK0HyCyJTGFLiDuTuduaksSDqMGNCmOfeu/mJfQ+d/S+qwkvQ1lONwNjihr2LBuxAR4CKk0Ik+hhVf+Zczurmj1mQn1eNizBoAN5h6Kr/t31+yW7h4Qg2hvmVcdzJGxcV2X4Sx9IgfDLqJTpJzIsuiKAJK6ZiWYZu3g1FX8K8JzSaubLxdXKj3AI0LaYbNpEINAcNv7cx0ZErsgdvLYfEa0V+QdDLnIhh0N4291jz/iYDuOncQf17gV32aq1mbm2mhh4ipGXPoNLdj34z1zi7VEn/FdOzuy+KduO8H05ZCJxzHvkD3mwFfjQdlN97jGgAI26rU/tkwm8yVyMx/4elcczwMZ+p5BcUmuegH+TD21Y6t4Efs4eLO7TOhWylg6LuZQ3eU4Kvl3PfOh+Qhy14G05AifLaOPuDHUqQ0v9w+uKcQibLQPFGBH8I85slgU7EoszZf/bS19pS7ckp1L40nKPFH0ncSykYknXQ1nhLawdOe2GibPHlB0bkqQ4j6lnqyH328qZRGN4sLeEJR/FMX2P7XUDHlnw/GEmB78MMsxZklZdbuJAaaGufXpvHkEj3sGDFiPne2xjMZ4Mt3HXF0gFKlexY4Wh9kd/S3856hGpqP+fGaYwAXWPt/l4BE+jzfq0TDG2Zc5R14Wi0pLK4xUL83xat2hPNKMRbgigQtVx6TlsWCkrADzuFu1EcuLR6gBVp2a5ak0yqzd+Cein/NQIYAQ=="
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: \"Not Applicable\" - No change needed, already matches the controlled terminology exactly.\n\n2. **assay**: Broadened from \"immunohistochemistry of skin\" to **\"immunohistochemistry\"** - Removed the tissue-specific qualifier \"of skin\" to use the standard, general assay method term from the controlled vocabulary.\n\n3. **tumorType**: Broadened from \"Cutaneous storiform neurofibroma\" to **\"Cutaneous Neurofibroma\"** - Removed the specific histological pattern descriptor \"storiform\" while retaining the anatomical location \"Cutaneous\" to match the controlled terminology. This represents the broader tumor category that encompasses the more specific storiform pattern variant."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3063,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 765
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3063,
          "output_tokens": 765,
          "total_tokens": 3828
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: Broadened \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" to \"Neurofibromatosis type 1\" - the chromosome 17q11.2 deletion is the genetic cause of NF1, so the broader diagnostic term is the standard classification.\n\n2. **assay**: Broadened \"cell viability assay using Annexin V staining\" to \"cell viability assay\" - removed the specific methodological detail (Annexin V staining) to use the general assay category.\n\n3. **tumorType**: Broadened \"Pedunculated Cutaneous Neurofibroma\" to \"Cutaneous Neurofibroma\" - removed the specific morphological descriptor (pedunculated) to use the standard general tumor type classification.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3085,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 555
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01McSSVsCYxT43h7oiX3gEGk",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Looking at the input data, I need to broaden narrow synonyms to match the exact controlled terminology values from the Target Schema:\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\"\n   - This is a specific description of Neurofibromatosis type 1 (NF1), which is caused by deletions in the chromosome 17q11.2 region containing the NF1 gene.\n   - Looking at the enum options, \"Neurofibromatosis type 1\" is available and is the broader, standard term for this condition.\n\n2. **assay**: \"cell viability assay using Annexin V staining\"\n   - This is a specific method for cell viability assay using Annexin V staining.\n   - Looking at the enum options, \"cell viability assay\" is available and is the broader term that encompasses various methods including Annexin V staining.\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\"\n   - This is a specific subtype of cutaneous neurofibroma.\n   - Looking at the enum options, \"Cutaneous Neurofibroma\" is available and is the broader, more general term.\n\nI need to make sure I use the exact values from the schema enums.",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: Broadened \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" to \"Neurofibromatosis type 1\" - the chromosome 17q11.2 deletion is the genetic cause of NF1, so the broader diagnostic term is the standard classification.\n\n2. **assay**: Broadened \"cell viability assay using Annexin V staining\" to \"cell viability assay\" - removed the specific methodological detail (Annexin V staining) to use the general assay category.\n\n3. **tumorType**: Broadened \"Pedunculated Cutaneous Neurofibroma\" to \"Cutaneous Neurofibroma\" - removed the specific morphological descriptor (pedunculated) to use the standard general tumor type classification."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3085,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 555
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3085,
          "output_tokens": 555,
          "total_tokens": 3640
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 with scoliosis\" \u2192 \"Neurofibromatosis type 1\" (removed the specific clinical manifestation \"with scoliosis\" to use the standard diagnosis term)\n\n2. **assay**: Broadened \"anti-tag immunocytochemistry\" \u2192 \"immunocytochemistry\" (removed the specific technique modifier \"anti-tag\" to use the standard assay term)\n\n3. **tumorType**: Broadened \"sessile cutaneous neurofibroma\" \u2192 \"Cutaneous Neurofibroma\" (removed the specific morphological descriptor \"sessile\" to use the standard tumor type term)",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3076,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 658
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01VfdND2BfX1FSzYz9WAahTm",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze the input data and broaden the narrow, specific terms to match the controlled terminology in the Target Schema.\n\nInput data:\n1. \"diagnosis\": \"Neurofibromatosis type 1 with scoliosis\"\n2. \"assay\": \"anti-tag immunocytochemistry\"\n3. \"tumorType\": \"sessile cutaneous neurofibroma\"\n\nNow I need to match these to the exact enum values in the Target Schema:\n\n1. For \"diagnosis\": \"Neurofibromatosis type 1 with scoliosis\"\n   - This is a narrow, specific term mentioning \"with scoliosis\"\n   - The broader standard term would be \"Neurofibromatosis type 1\" (which is in the enum)\n   - The scoliosis is a specific manifestation/complication but the base diagnosis is NF1\n\n2. For \"assay\": \"anti-tag immunocytochemistry\"\n   - This is a specific type of immunocytochemistry using anti-tag antibodies\n   - The broader standard term would be \"immunocytochemistry\" (which is in the enum)\n\n3. For \"tumorType\": \"sessile cutaneous neurofibroma\"\n   - \"sessile\" is a descriptor meaning attached directly by its base without a stalk\n   - \"cutaneous\" refers to the skin\n   - The broader standard term would be \"Cutaneous Neurofibroma\" (which is in the enum)\n\nLet me verify these are exact matches in the enums:\n- \"Neurofibromatosis type 1\" - YES, it's in the diagnosis enum\n- \"immunocytochemistry\" - YES, it's in the assay enum\n- \"Cutaneous Neurofibroma\" - YES, it's in the tumorType enum\n\nAll match exactly as they appear in the Target Schema.",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **diagnosis**: Broadened \"Neurofibromatosis type 1 with scoliosis\" \u2192 \"Neurofibromatosis type 1\" (removed the specific clinical manifestation \"with scoliosis\" to use the standard diagnosis term)\n\n2. **assay**: Broadened \"anti-tag immunocytochemistry\" \u2192 \"immunocytochemistry\" (removed the specific technique modifier \"anti-tag\" to use the standard assay term)\n\n3. **tumorType**: Broadened \"sessile cutaneous neurofibroma\" \u2192 \"Cutaneous Neurofibroma\" (removed the specific morphological descriptor \"sessile\" to use the standard tumor type term)"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3076,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 658
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3076,
          "output_tokens": 658,
          "total_tokens": 3734
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - Peripheral neurofibromatosis is the historical/narrow term for NF1, which is the standard terminology\n\n2. **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\"\n   - \"Wide bore\" refers to the scanner's physical dimensions, not the assay type. Broadened to the standard general MRI term\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Unknown\"\n   - Mapped to the appropriate controlled vocabulary term for cases without a clear diagnosis",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3060,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 584
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01MPANhvTGpX5bWjW27b5k7X",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze the input data and map it to the controlled terminology in the Target Schema:\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\"\n   - This is a narrow/specific term for Neurofibromatosis type 1 (NF1)\n   - Peripheral neurofibromatosis is the historical name for NF1\n   - Looking at the enum values, I see \"Neurofibromatosis type 1\" which is the standard term\n   - This should map to: \"Neurofibromatosis type 1\"\n\n2. **assay**: \"wide bore MRI\"\n   - This is a specific type of MRI scanner (referring to the bore width)\n   - Looking at the enum values, I see several MRI-related options:\n     - \"conventional MRI\"\n     - \"diffusion MRI\"\n     - \"functional MRI\"\n     - \"structural MRI\"\n     - \"resting state functional MRI\"\n     - \"Magnetization-Prepared Rapid Gradient Echo MRI\"\n   - \"wide bore MRI\" is a scanner specification, not an assay type\n   - The broadest/most general MRI term would be \"conventional MRI\"\n   - This should map to: \"conventional MRI\"\n\n3. **tumorType**: \"no clear diagnosis\"\n   - This indicates uncertainty or lack of clear diagnosis\n   - Looking at the enum values, I see:\n     - \"Unknown\"\n     - \"Not Applicable\"\n   - \"Unknown\" seems most appropriate for when there's no clear diagnosis\n   - This should map to: \"Unknown\"\n\nLet me create the corrected JSON output.",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections made:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - Peripheral neurofibromatosis is the historical/narrow term for NF1, which is the standard terminology\n\n2. **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\"\n   - \"Wide bore\" refers to the scanner's physical dimensions, not the assay type. Broadened to the standard general MRI term\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Unknown\"\n   - Mapped to the appropriate controlled vocabulary term for cases without a clear diagnosis"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3060,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 584
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3060,
          "output_tokens": 584,
          "total_tokens": 3644
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" \u2192 \"NF2-related schwannomatosis\"\n   - Acoustic neurofibromatosis is an outdated term for what is now called NF2-related schwannomatosis, characterized by bilateral vestibular schwannomas\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\"\n   - The specific methodology detail (ribosomal RNA depletion) is broadened to the general standard term for the assay type\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\"\n   - \"Acoustic neuroma\" is a colloquial term for vestibular schwannoma, and the specific anatomical details (left vestibular nerve) are removed to use the broader, standard tumor classification term",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3073,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 834
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_012gYKJ7LiHt37vyk4hWihrn",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Let me analyze each field and broaden the narrow synonyms to the controlled terminology:\n\n1. **diagnosis**: \"acoustic neurofibromatosis\"\n   - \"Acoustic neurofibromatosis\" is an older term for what is now known as Neurofibromatosis type 2 (NF2) or NF2-related conditions\n   - Looking at the enum options, I see:\n     - \"NF2-related schwannomatosis\"\n     - \"Neurofibromatosis type 1\"\n     - \"Vestibular Schwannoma\"\n   - Acoustic neurofibromatosis is the old name for NF2, which is characterized by bilateral vestibular schwannomas\n   - The most appropriate broader term would be \"NF2-related schwannomatosis\" as this is the modern terminology for what was previously called acoustic neurofibromatosis\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\"\n   - This is a specific type of RNA-seq methodology\n   - The broader, standard term in the enum is simply \"RNA-seq\"\n   - I should use the exact value: \"RNA-seq\"\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\"\n   - \"Acoustic neuroma\" is an older/colloquial term for vestibular schwannoma\n   - Looking at the enum, I see \"Schwannoma\" and \"Vestibular Schwannoma\" are not in the list... wait, let me check again\n   - I see \"Schwannoma\" in the enum list\n   - The broader, more general term would be \"Schwannoma\" since it doesn't need to specify which nerve or which side\n\nLet me double-check the enum values:\n- For tumorType, I don't see \"Vestibular Schwannoma\" but I do see \"Schwannoma\"\n- Wait, I need to look more carefully at the diagnosis enum - there IS \"Vestibular Schwannoma\" in the diagnosis enum\n\n\nI've mapped the specific terms to their broader, standardized equivalents. Each field now uses a more general, controlled terminology that captures the essential information while aligning with the available enum options.",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" \u2192 \"NF2-related schwannomatosis\"\n   - Acoustic neurofibromatosis is an outdated term for what is now called NF2-related schwannomatosis, characterized by bilateral vestibular schwannomas\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" \u2192 \"RNA-seq\"\n   - The specific methodology detail (ribosomal RNA depletion) is broadened to the general standard term for the assay type\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" \u2192 \"Schwannoma\"\n   - \"Acoustic neuroma\" is a colloquial term for vestibular schwannoma, and the specific anatomical details (left vestibular nerve) are removed to use the broader, standard tumor classification term"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3073,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 834
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3073,
          "output_tokens": 834,
          "total_tokens": 3907
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n- **diagnosis**: Broadened \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" to the standard term \"Neurofibromatosis type 1\"\n- **assay**: Broadened the specific assay \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" to the general category \"3D microtissue viability\"\n- **tumorType**: Broadened the specific subtype \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" to the broader term \"Malignant Peripheral Nerve Sheath Tumor\"",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3106,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 681
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01UhxKQsiWgCAdQ476VuPRtP",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "thinking",
                "thinking": "Looking at the input data, I need to map each field to the controlled vocabulary in the Target Schema:\n\n1. **diagnosis**: \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\"\n   - This is a narrow, specific description of Neurofibromatosis type 1\n   - The broader term in the enum is: \"Neurofibromatosis type 1\"\n\n2. **assay**: \"CellTiter-Glo\u00ae 3D Cell Viability Assay\"\n   - This is a specific assay name that is a 3D cell viability assay\n   - Looking at the enum, I can see \"3D microtissue viability\" and \"cell viability assay\"\n   - Since this is specifically a 3D viability assay, \"3D microtissue viability\" seems most appropriate\n   - Actually, looking more carefully, \"cell viability assay\" is more general and could apply to both 2D and 3D\n   - But there's also \"3D microtissue viability\" which is specifically for 3D\n   - CellTiter-Glo 3D is specifically designed for 3D cultures/microtissues, so \"3D microtissue viability\" is the best match\n\n3. **tumorType**: \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\"\n   - This is a specific subtype of MPNST\n   - The broader term in the enum is: \"Malignant Peripheral Nerve Sheath Tumor\"\n\nLet me verify these mappings:\n- \"Neurofibromatosis type 1\" \u2713 (exists in diagnosis enum)\n- \"3D microtissue viability\" \u2713 (exists in assay enum)\n- \"Malignant Peripheral Nerve Sheath Tumor\" \u2713 (exists in tumorType enum)",
                "signature": "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"
              },
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Changes made:**\n- **diagnosis**: Broadened \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" to the standard term \"Neurofibromatosis type 1\"\n- **assay**: Broadened the specific assay \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" to the general category \"3D microtissue viability\"\n- **tumorType**: Broadened the specific subtype \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" to the broader term \"Malignant Peripheral Nerve Sheath Tumor\""
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3106,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 681
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3106,
          "output_tokens": 681,
          "total_tokens": 3787
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.9333333333333332,
      "min_score": 0.6666666666666666,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 117.19319105148315,
    "token_usage": {
      "input_tokens": 30758,
      "output_tokens": 6925,
      "total_tokens": 37683
    }
  }
}